Searchable abstracts of presentations at key conferences in endocrinology

ea0073ep164 | Pituitary and Neuroendocrinology | ECE2021

Is hypoprolactinemia also associated with sexual dysfunction?

Can Erdi Zuleyha , Ozkan Cigdem

Our knowledge about sexual dysfunction during the treatment of patients with prolactinoma is limited. The sexual dysfunction may not improve or turn out a different form as in our patient. Delayed ejeculation (DE) is a complex form of male sexual dysfuntion, characterized by a considerable delay in ejaculation or an inability to complete ejaculation. Both organic and psychogenic etiologies can cause DE, however the pathophysiology is indefinite. In this case, we present a male...

ea0073ep232 | Late Breaking | ECE2021

Evaluation of awareness about requirement of anti-obesity pharmacotheraphy before weight loss surgery in a tertiary outpatient Endocrine Clinic in Turkey

Can Erdi Zuleyha , Ozkan Cigdem , Mucteba Ozturk Ahmet , Bas Koray

BackgroundObesity is an increasing public health problem all around the world. It plays role in the pathogenesis of many diseases, especially diabetes, hypertension, hyperlipidemia, cardiovascular diseases and cancer. The prevalence of weight-loss surgery is increasing as a result of developments of surgical techniques. In parallel with these developments, more patients admit for weight-loss surgery. Pharmacotherapy is one of the most important component...

ea0090p690 | Pituitary and Neuroendocrinology | ECE2023

Evaluation of Serum Omentin-1 Levels and Atherosclerotic Risk Factors in Patients with Prolactinoma

Can Erdi Zuleyha , Ozkan Cigdem , Ozgur Ceylan Mustafa , Eren Guzel Hamza , Ercan Gizem , Bozkaya Giray , Hilal Adibelli Zehra

Background: Prolactinoma is the most common functioning pituitary adenoma. Subclinical atherosclerosis and cardiovascular risk in patients with prolactinoma were reported but have not been clarified yet.Aim: Our study aims to compare prolactinoma patients with a control group in terms of lipid profile, body fat distribution, and subclinical atherosclerosis markers.Methods: This single-center, prospective study included 32 patients ...